德克萨米他与5-HT3受体对抗剂在清醒时切除期间预防恶心:一种倾向性得分匹配研究
1Department of Anesthesiology, Nagoya University Hospital, Nagoya City, Aichi, 466-8550, Japan. takesato@med.nagoya-u.ac.jp.
JA clinical reports
|October 7, 2024
概括
德克萨米他在预防清醒时骨切割 (AC) 期间的恶心方面比格拉尼斯特更有效. 这项研究发现,在接受德克萨米他治疗的患者中,恶心发生率显著降低,而不是格拉尼斯特龙.
科学领域:
- 神经外科 神经外科
- 麻醉学 麻醉学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在醒着的骨切除术 (AC) 期间的恶心和吐会带来诸如大脑压力增加和吸血等风险.
- 5-HT3受体对抗剂 (例如,格拉尼塞特龙) 是在AC期间预防恶心的标准.
- 德克萨米他在AC中的抗效应需要进一步研究.
研究的目的:
- 为了比较德克萨米他和格拉尼塞特朗在预防AC期间恶心的疗效.
- 评估AC患者中恶心和吐的发生率,这些患者接受了德克萨米他或格拉尼塞特朗治疗.
主要方法:
- 一项对170名AC患者的回顾性研究 (截至2019年9月).
- 患者在醒来之前接受了德克萨米他 (n=71) 或格拉尼塞特龙 (n=99).
- 倾向性得分 (PS) 匹配用于比较82名选定的患者的结果.
主要成果:
- 在德克萨米他组 (9.8%) 的恶心发病率明显低于格瑞塞组 (41.5%) (p=0.002).
- 在PS匹配后的逻辑回归证实,甲松显著降低了恶心发生率 (OR:0.12,95% CI:0.029-0.499,p=0.03).
结论:
- 德克萨米他在预防清醒时的头骨切割过程中的恶心方面表现出比格拉尼塞特龙更高的疗效.
- 德克萨米他对AC患者来说是一种潜在的更有效的预防性抗药剂.
相关概念视频
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
179
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
179
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
152
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
152
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
151
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
151
01:19Depolarizing Blockers: Pharmocokinetics
315
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
315
01:31Skeletal Muscle Relaxants: Therapeutic Uses
475
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
475